CEP
ELV icon

Chicago Equity Partners’s Elevance Health ELV Stock Holding History

Chicago Equity Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$450K Sell
1,980
-400
-17% -$109K 0.05% 454
2019
Q4 		$719K Sell
2,380
-930
-28% -$256K 0.04% 551
2019
Q3 		$795K Sell
3,310
-6,445
-66% -$1.77M 0.04% 564
2019
Q2 		$2.75M Buy
9,755
+25
+0.3% +$6.83K 0.12% 242
2019
Q1 		$2.79M Sell
9,730
-847
-8% -$245K 0.11% 256
2018
Q4 		$2.78M Sell
10,577
-2,665
-20% -$733K 0.11% 266
2018
Q3 		$3.63M Sell
13,242
-18,153
-58% -$4.71M 0.11% 268
2018
Q2 		$7.47M Sell
31,395
-250
-0.8% -$57.9K 0.23% 124
2018
Q1 		$6.95M Buy
31,645
+20,290
+179% +$4.77M 0.22% 135
2017
Q4 		$2.56M Sell
11,355
-125
-1% -$26.6K 0.08% 321
2017
Q3 		$2.18M Sell
11,480
-35
-0.3% -$6.66K 0.07% 353
2017
Q2 		$2.17M Buy
11,515
+4,105
+55% +$738K 0.06% 355
2017
Q1 		$1.23M Buy
7,410
+1,040
+16% +$165K 0.04% 424
2016
Q4 		$916K Sell
6,370
-85,120
-93% -$11.4M 0.02% 479
2016
Q3 		$11.5M Sell
91,490
-1,985
-2% -$256K 0.32% 88
2016
Q2 		$12.3M Sell
93,475
-2,685
-3% -$367K 0.36% 83
2016
Q1 		$13.4M Sell
96,160
-10,250
-10% -$1.37M 0.39% 77
2015
Q4 		$14.8M Sell
106,410
-4,220
-4% -$581K 0.39% 81
2015
Q3 		$15.5M Sell
110,630
-61,795
-36% -$9.29M 0.43% 77
2015
Q2 		$28.3M Sell
172,425
-16,145
-9% -$2.58M 0.77% 34
2015
Q1 		$29.1M Sell
188,570
-12,350
-6% -$1.76M 0.78% 37
2014
Q4 		$25.3M Sell
200,920
-10,405
-5% -$1.29M 0.68% 44
2014
Q3 		$25.3M Sell
211,325
-270
-0.1% -$31K 0.67% 51
2014
Q2 		$22.8M Buy
211,595
+40,390
+24% +$4.16M 0.6% 58
2014
Q1 		$17M Buy
171,205
+117,065
+216% +$10.6M 0.47% 76
2013
Q4 		$5M Buy
54,140
+19,965
+58% +$1.77M 0.15% 150
2013
Q3 		$2.86M Buy
34,175
+8,030
+31% +$688K 0.09% 186
2013
Q2 		$2.14M Buy
+26,145
New +$1.96M 0.07% 208

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chicago Equity Partners's ELV Position: Q1 2020 in Review

Chicago Equity Partners reduced its Elevance Health (ELV) stake by 17% in Q1 2020, selling an estimated $109K and leaving 1,980 shares worth $450K. The position accounts for 0.05% of the portfolio, ranked #454.

Chicago Equity Partners first reported a position in ELV in Q2 2013 and has held it in 28 quarters since. The position peaked at $29.1M in Q1 2015. 1,053 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Chicago Equity Partners held 1,980 shares of Elevance Health worth $450K as of Q1 2020.
  • Chicago Equity Partners sold 400 Elevance Health shares in Q1 2020, an estimated $109K.
  • Elevance Health made up 0.05% of Chicago Equity Partners's portfolio in Q1 2020, its #454 holding.
  • Chicago Equity Partners first reported a position in Elevance Health in Q2 2013 and has held it in 28 quarters since.
  • Chicago Equity Partners's Elevance Health position peaked at $29.1M in Q1 2015.
  • 1,053 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.